Dr Klaus Trier
Klaus Trier, MD, is an ophthalmologist and Co-founder of Theialife. Dr Trier earned his medical degree from The University of Copenhagen in 1983 and qualified as an eye specialist in 1990.
He founded and leads Trier Research Laboratories in Hellerup, Denmark and is the principal investigator behind two decades of Danish clinical research of 7-methylxanthine as a treatment for childhood myopia progression.
Contact info
- Website:
- https://www.theialife.com/
ArticleTargeting childhood myopia progression with 7-methylxanthine
Childhood myopia researcher Dr Klaus Trier explores how 7-methylxanthine targets scleral remodelling and axial elongation, and its potential to slow disease progression and reduce the risk of high myopia.